← Eichor
Study identifier: NCT06049459 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Novel Amblyopia Treatment With Virtual Reality Games

Condition: Amblyopia  ·  Sponsor: Marjean Kulp

PhaseNA
Planned participants8
Who can joinAll sexes, 5 Years to 17 Years
Healthy volunteersNo

About this study

The goal of this study is to compare the change in amblyopic eye acuity between treatment periods in children with amblyopia, aged 5-17 years. The main question it aims to answer is: Is a 16-week course of amblyopia treatment using Vivid Vision Therapeutic (Dichoptic) Virtual Reality Games for approx. 25 min/day, 6 days/week more effective for improvement in amblyopic-eye VA, binocularity (stereoacuity, suppression, alignment), contrast sensitivity, attention, oculomotor function, visual-motor integration, and quality of life than 16 weeks of continued glasses alone? Participants will each serve as their own control and complete: Treatment period 1: Continued optical correction (glasses) alone for 16 weeks; Treatment period 2: Vivid Vision Therapeutic (Dichoptic) Virtual Reality Games for 16 weeks (approx. 25min/day, 6 days/week) plus continued optical correction

This description comes directly from the study's public registry record.

Talk to the study team

Marjean T Kulp, OD, MS  ·  614-688-3336  ·  kulp.6@osu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The Ohio State University College of OptometryColumbus, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06049459